Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Individual Treatment for H. Pylori Infection
NCT02689583Unknown
- Sponsor
- First Affiliated Hospital, Zhejiang University School of Medicine
- Start
- Mar 2016
- Primary completion
- Mar 2017
- Modality
- Small Molecules
01
Overview
Open-label, single-arm trial of amoxicillin, clarithromycin, levofloxacin, tetracycline, furazolidone and 3 more in Helicobacter pylori infection, sponsored by First Affiliated Hospital, Zhejiang University School of Medicine. Primary endpoints: Eradication rates of H. pylori at 3 months, Mutation site of drug resistance gene at 3 months and 1 more. Status: unknown.
02
Drugs
amoxicillinclarithromycinlevofloxacintetracyclinefurazolidone
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT02689583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02689583.